Back
ESC Premium Access

Lipid-lowering therapy in primary prevention: where will we be 10 years from now

Session: Cholesterol-lowering therapy for primary and secondary prevention
Topic: Lipids (Epidemiology and Prevention)
Speaker: Professor A. Catapano (Milan, IT)
Event: ESC Congress 2017

Congress Presentation

About the speaker

Professor Alberico Catapano

IRCCS - MultiMedica, Milan (Italy)
46 presentations
3 followers

4 more presentations in this session

State of the Art: cholesterol-lowering therapy for primary and secondary prevention

Speaker: Doctor J. Robinson (Iowa, US)

Access
Slides
Video
Thumbnail

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and incident type 2 diabetes mellitus: a systematic review and meta-analysis with over 10,000 patients

Speaker: Doctor L. Carvalho (Brasilia, BR)

Access
Abstract
Slides
Video
Thumbnail

Effect of the magnitude of LDL lowering on the incidence of cataract among patients treated with statins or PCSK9 antibodies

Speaker: Doctor J. Kostis (New Brunswick, US)

Access
Abstract
Slides
Video
Thumbnail

Comparison of the low-density lipoprotein cholesterol target value and the preventive effect of statins in elderly patients and younger patients

Speaker: Doctor A. Endo (Izumo, JP)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Cholesterol-lowering therapy for primary and secondary prevention

Speakers: Professor A. Catapano, Doctor J. Robinson, Doctor L. Carvalho, Doctor J. Kostis, Doctor A. Endo
Access
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb